Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greenfield, MA
NPI
1770743999
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
329 Conway St
Greenfield, MA, 01301
Phone (413) 774-6301
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
4,873 services
Medicare patients, 2024
478
Average age 72
Drug cost, 2024
$2.3M
5,017 prescriptions
Company payments, 2025
$28.05
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Spitzer was code 99214 (office e&m - established), 715 times for 370 patients. In total Matthew J Spitzer billed 4,873 services in 74 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 715 | 370 | $92.52 | $66K |
| 36415 Venipuncture Blood Collection | Office | 526 | 302 | $8.63 | $4,541 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 517 | 321 | $12.62 | $6,523 |
| 83036 Blood Count | Office | 287 | 162 | $9.49 | $2,723 |
| 84443 Clinical Chemistry | Office | 265 | 167 | $16.27 | $4,313 |
| 95251 Test - Miscellaneous | Office | 234 | 107 | $26.37 | $6,169 |
| 82306 Clinical Chemistry | Office | 208 | 153 | $28.87 | $6,005 |
| 83735 Clinical Chemistry | Office | 175 | 128 | $6.53 | $1,143 |
| 82570 Clinical Chemistry | Office | 156 | 109 | $5.08 | $792 |
| 82043 Clinical Chemistry | Office | 156 | 109 | $5.66 | $883 |
| 84439 Clinical Chemistry | Office | 150 | 80 | $8.72 | $1,308 |
| 80053 Clinical Chemistry | Office | 148 | 120 | $10.28 | $1,521 |
| 80069 Clinical Chemistry | Office | 146 | 104 | $8.45 | $1,234 |
| 80061 Clinical Chemistry | Office | 139 | 116 | $13.03 | $1,811 |
| 83970 Clinical Chemistry | Office | 111 | 83 | $40.45 | $4,490 |
By year: 2022 $128K for 4,899 services; 2023 $145K for 4,562 services; 2024 $145K for 4,873 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 526 | 302 | $8.63 | $4,541 |
| 83036 Blood Count | 287 | 162 | $9.49 | $2,723 |
| 84443 Clinical Chemistry | 265 | 167 | $16.27 | $4,313 |
| 82306 Clinical Chemistry | 208 | 153 | $28.87 | $6,005 |
| 83735 Clinical Chemistry | 175 | 128 | $6.53 | $1,143 |
| 82043 Clinical Chemistry | 156 | 109 | $5.66 | $883 |
| 82570 Clinical Chemistry | 156 | 109 | $5.08 | $792 |
| 84439 Clinical Chemistry | 150 | 80 | $8.72 | $1,308 |
| 80053 Clinical Chemistry | 148 | 120 | $10.28 | $1,521 |
| 80069 Clinical Chemistry | 146 | 104 | $8.45 | $1,234 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Spitzer prescribed most often to Medicare patients was Levothyroxine Sodium, with 545 prescriptions and refills. In total Matthew J Spitzer wrote 5,017 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 545 | 1,384 | 129 | $6,283 |
| Ozempic Semaglutide | 231 | 364 | 50 | $334K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 193 | 524 | 88 | $28K |
| Jardiance Empagliflozin | 182 | 405 | 44 | $232K |
| Mounjaro Tirzepatide | 171 | 247 | 35 | $276K |
| Atorvastatin Calcium Generic | 149 | 376 | 36 | $2,074 |
| Testosterone Cypionate Generic | 140 | 140 | 20 | $6,034 |
| Metformin Hcl Generic | 139 | 281 | 28 | $1,082 |
| Metformin Hcl Er Metformin Hcl | 137 | 384 | 38 | $2,216 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 133 | 339 | 54 | $34K |
| Lisinopril Generic | 122 | 338 | 37 | $816 |
| Rosuvastatin Calcium Generic | 107 | 285 | 31 | $4,737 |
| Alendronate Sodium Generic | 106 | 297 | 38 | $1,035 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 93 | 189 | 40 | $147K |
| Losartan Potassium Generic | 82 | 223 | 23 | $719 |
Brand drugs: 2,068 claims; generic drugs: 2,491 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew J Spitzer $28.05 ($28.05 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $28.05.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $28.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.